<div id="readability-page-1"><p><span>GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report)</span> had its target price lowered by equities researchers at Argus  from $95.00 to $80.00 in a research note issued on Tuesday,MarketScreener reports. The firm presently has a &#34;buy&#34; rating on the stock. Argus' price objective would suggest a potential upside of 28.92% from the stock's current price.</p><ul><li>GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine</li></ul><p>Several other equities research analysts have also issued reports on GEHC. JPMorgan Chase &amp; Co. cut their price target on GE HealthCare Technologies from $80.00 to $65.00 and set a &#34;neutral&#34; rating for the company in a research note on Thursday, April 30th. Mizuho reduced their target price on shares of GE HealthCare Technologies from $90.00 to $80.00 in a research note on Thursday, April 30th. BNP Paribas Exane dropped their price target on shares of GE HealthCare Technologies from $95.00 to $88.00 in a research note on Friday, May 1st. Evercore  set a $80.00 price objective on shares of GE HealthCare Technologies in a research note on Thursday, April 30th. Finally, Barclays dropped their target price on GE HealthCare Technologies from $87.00 to $78.00 and set an &#34;equal weight&#34; rating on the stock in a research report on Thursday, April 30th. Nine research analysts have rated the stock with a Buy rating, eight have assigned  a Hold rating and one  has given a Sell rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies  has an average rating of &#34;Hold&#34; and an average price target of $80.63.</p><p><b>Get Our Latest Report on GEHC</b></p><h2>GE HealthCare Technologies Stock Up 0.9%</h2><ul><li>Honeywell’s Breakup: Is HON Stock a Sweet Deal for Investors?</li></ul><p>GEHC traded up $0.54 during trading on Tuesday, hitting $62.05. 1,765,974 shares of the company's stock were exchanged, compared to its average volume of 4,147,691. The stock has a market cap of $28.23 billion, a P/E ratio of 14.89, a PEG ratio of 1.37 and a beta of 0.74. The business's 50 day moving average is $69.27 and its two-hundred day moving average is $76.59. GE HealthCare Technologies has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. </p><p>GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts' consensus estimates of $1.07 by ($0.08). The business had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The company's revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS.  As a group, equities analysts expect that  GE HealthCare Technologies will post 4.89 earnings per share for the current fiscal year. </p><h2>Insider Buying and Selling at GE HealthCare Technologies</h2><ul><li>Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play</li></ul><p>In other news, insider Frank R. Jimenez acquired 1,750 shares of the firm's stock in a transaction that occurred on Thursday, April 30th. The stock was purchased at an average price of $60.45 per share, with a total value of $105,787.50. Following the purchase, the insider owned 93,932 shares of the company's stock, valued at approximately $5,678,189.40. This trade represents a 1.90% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Rodney F. Hochman acquired 1,618 shares of the stock in a transaction on Tuesday, May 12th. The shares were purchased at an average price of $62.03 per share, for a total transaction of $100,364.54. Following the completion of the transaction, the director owned 1,618 shares in the company, valued at approximately $100,364.54. This represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. Over the last quarter, insiders acquired 11,847 shares of company stock valued at $719,555. Corporate insiders own  0.36% of the company's stock. </p><h2>Hedge Funds Weigh In On GE HealthCare Technologies</h2><p>Institutional investors and hedge funds have recently bought and sold shares of the business. Laurel Wealth Advisors LLC bought a new position in  GE HealthCare Technologies in the 4th quarter worth approximately $26,000.  Optima Capital LLC acquired a new position in  GE HealthCare Technologies during the fourth quarter valued at approximately $27,000.  Godfrey Financial Associates Inc. acquired a new stake in shares of  GE HealthCare Technologies in the 4th quarter valued at approximately $27,000.  Montag A &amp; Associates Inc. increased its holdings in  GE HealthCare Technologies by 105.4% during the fourth quarter. Montag A &amp; Associates Inc. now owns 341 shares of the company's stock worth $28,000 after buying an additional 175 shares during the last quarter.  Finally, Transamerica Financial Advisors LLC raised its position in  GE HealthCare Technologies by 331.6% during the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company's stock worth $28,000 after acquiring an additional 262 shares in the last quarter. Hedge funds and other institutional investors own  82.06% of the company's stock. </p><h2>GE HealthCare Technologies Company Profile</h2> (Get Free Report)<p>GE HealthCare Technologies <span>NASDAQ: GEHC<span></span></span> is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.  </p><p>In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than GE HealthCare Technologies</li><li>Nebius Group Pulls Back 9% After a Downgrade Despite Strong Earnings</li><li>Rewiring AI: NextEra Energy Sparks a Mega Merger</li><li>Flipping the Switch: Is Ford the Next Big Energy Stock?</li><li>Does Nano Nuclear Energy’s New Deal Amp the Outlook?</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in GE HealthCare Technologies Right Now?</h2><p>Before you consider GE HealthCare Technologies, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.</p><p>While GE HealthCare Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

GEHC

<p>Analysts at Argus have lowered their price target for GE HealthCare Technologies (NASDAQ:GEHC) from $95.00 to $80.00, maintaining a 'buy' rating. Other firms like JPMorgan and Mizuho have also adjusted their targets, with JPMorgan setting it at $65.00. Currently, GEHC's stock trades at $62.05, with an average price target of $80.63 from analysts. The company reported earnings of $0.99 per share, missing estimates, but revenue increased by 7.4% year-over-year.</p>

Market Beat

GE HealthCare Tech

iShares US Medical Devices

SPDR S&P Health Equip

JPMorgan Chase

Mizuho Financial

Mizuho Financial Group, Inc.

BNP Paribas

Evercore

Barclays

GE Aerospace

Honeywell

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Honeywell International - WI

GE HealthCare Technologies (NASDAQ:GEHC) Price Target Cut to $80.00 by Analysts at Argus